Total Payments
$2,404
2024 Payments
$270.08
Companies
33
Transactions
81
Medicare Patients
7,113
Medicare Billing
$531,485
Payment Breakdown by Category
Food & Beverage$2,316 (96.3%)
Education$88.00 (3.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,316 | 80 | 96.3% |
| Education | $88.00 | 1 | 3.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $306.20 | 5 | $0 (2021) |
| Myriad Genetic Laboratories, Inc. | $279.78 | 2 | $0 (2023) |
| Astellas Pharma US Inc | $176.32 | 7 | $0 (2024) |
| Janssen Biotech, Inc. | $152.50 | 4 | $0 (2018) |
| Cook Medical LLC | $138.90 | 2 | $0 (2019) |
| Verity Pharmaceuticals Inc. | $130.86 | 7 | $0 (2024) |
| ABBVIE INC. | $128.11 | 8 | $0 (2024) |
| Coloplast Corp | $122.82 | 6 | $0 (2022) |
| Ferring Pharmaceuticals Inc. | $103.33 | 1 | $0 (2017) |
| Bayer HealthCare Pharmaceuticals Inc. | $90.52 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $270.08 | 12 | Tempus AI, Inc ($50.46) |
| 2023 | $487.12 | 13 | Myriad Genetic Laboratories, Inc. ($279.78) |
| 2022 | $291.52 | 12 | Rochester Medical Corporation ($61.21) |
| 2021 | $232.99 | 12 | Dendreon Pharmaceuticals LLC ($69.43) |
| 2020 | $51.93 | 3 | Allergan, Inc. ($24.17) |
| 2019 | $391.61 | 9 | Cook Medical LLC ($138.90) |
| 2018 | $245.28 | 9 | Janssen Biotech, Inc. ($116.57) |
| 2017 | $433.69 | 11 | Dendreon Pharmaceuticals LLC ($132.16) |
All Payment Transactions
81 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $23.18 | General |
| 08/19/2024 | Boston Scientific Corporation | AMS 800 Artificial Urinary Sphincter (Device) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: AMS 800_URO | ||||||
| 06/25/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $27.28 | General |
| 06/07/2024 | Teleflex LLC | — | Food and Beverage | In-kind items and services | $41.35 | General |
| 05/14/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/15/2024 | 180 Medical, Inc. | GENTLECATH GLIDE (Device) | Food and Beverage | In-kind items and services | $29.18 | General |
| Category: CONTINENCE CARE | ||||||
| 03/11/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $19.92 | General |
| Category: Prostate cancer | ||||||
| 03/07/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: UROLOGY | ||||||
| 03/05/2024 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: LithoVue_URO | ||||||
| 01/31/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Oncology | ||||||
| 01/27/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: UROLOGY | ||||||
| 01/11/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/20/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Urology | ||||||
| 12/15/2023 | KOELIS Inc. | Trinity (Device) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Urology | ||||||
| 12/13/2023 | Myriad Genetic Laboratories, Inc. | — | Food and Beverage | In-kind items and services | $259.06 | General |
| 12/13/2023 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: ONCOLOGY | ||||||
| 11/27/2023 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $19.52 | General |
| Category: Prostate cancer | ||||||
| 10/18/2023 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $21.71 | General |
| Category: Prostate cancer | ||||||
| 09/19/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Oncology | ||||||
| 09/11/2023 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $18.38 | General |
| Category: Prostate cancer | ||||||
| 07/26/2023 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 07/17/2023 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $16.92 | General |
| Category: Prostate cancer | ||||||
| 05/16/2023 | Cardinal Health 414 LLC | — | Food and Beverage | In-kind items and services | $13.47 | General |
| 05/02/2023 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $19.72 | General |
| Category: Prostate cancer | ||||||
| 01/26/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: HORMONE THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,766 | 2,897 | $675,475 | $160,852 |
| 2022 | 23 | 1,822 | 2,347 | $615,160 | $122,004 |
| 2021 | 24 | 1,908 | 2,566 | $687,150 | $140,402 |
| 2020 | 26 | 1,617 | 3,453 | $533,131 | $108,228 |
Total Patients
7,113
Total Services
11,263
Medicare Billing
$531,485
Procedure Codes
99
All Medicare Procedures & Services
99 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1952 | Leuprolide injectable, camcevi, 1 mg | Office | 2023 | 14 | 672 | $134,400 | $44,048 | 32.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 230 | 263 | $65,750 | $24,133 | 36.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 82 | 101 | $59,590 | $17,337 | 29.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 240 | 282 | $49,350 | $15,885 | 32.2% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 14 | 108 | $111,000 | $14,720 | 13.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 70 | 70 | $26,250 | $8,296 | 31.6% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 14 | 15 | $24,000 | $5,099 | 21.2% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 165 | 212 | $21,200 | $3,727 | 17.6% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 12 | 12 | $13,170 | $2,783 | 21.1% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 22 | 24 | $49,400 | $2,644 | 5.4% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 15 | 15 | $8,415 | $2,525 | 30.0% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 19 | 58 | $14,268 | $2,455 | 17.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 32 | 32 | $8,960 | $2,386 | 26.6% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 49 | 54 | $5,400 | $2,197 | 40.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 29 | 29 | $3,770 | $2,010 | 53.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 166 | 213 | $5,964 | $1,769 | 29.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $5,490 | $1,559 | 28.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 15 | 15 | $7,170 | $1,554 | 21.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 338 | 452 | $14,012 | $986.67 | 7.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 26 | 28 | $3,360 | $952.83 | 28.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 108 | 125 | $24,000 | $872.66 | 3.6% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 26 | 37 | $4,810 | $848.10 | 17.6% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 11 | 11 | $3,223 | $733.81 | 22.8% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 15 | 15 | $7,350 | $678.90 | 9.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 28 | 28 | $2,324 | $441.00 | 19.0% |
About Dr. Christopher Whelan, MD
Dr. Christopher Whelan, MD is a Urology healthcare provider based in Rockford, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1275745267.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Whelan, MD has received a total of $2,404 in payments from pharmaceutical and medical device companies, with $270.08 received in 2024. These payments were reported across 81 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($2,316).
As a Medicare-enrolled provider, Whelan has provided services to 7,113 Medicare beneficiaries, totaling 11,263 services with total Medicare billing of $531,485. Data is available for 4 years (2020–2023), covering 99 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Rockford, IL
- Active Since 05/04/2007
- Last Updated 09/05/2025
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1275745267
Products in Payments
- PROVENGE (Drug) $306.20
- Cook Medical Stents (Device) $138.90
- Trelstar (Drug) $130.86
- FIRMAGON (Drug) $103.33
- Erleada (Drug) $99.96
- Xofigo (Drug) $90.52
- LUPRON DEPOT (Drug) $89.24
- ORGOVYX (Drug) $72.81
- GEMTESA (Drug) $66.97
- SPEEDICATH (Device) $62.16
- XTANDI (Drug) $55.06
- ZYTIGA (Drug) $52.54
- NANOKNIFE (Device) $48.74
- SpeediCath (Device) $43.23
- Xtandi (Drug) $33.88
- Axumin (Drug) $32.79
- Dornier Medilas H Solvo (Device) $31.24
- GENTLECATH GLIDE (Device) $29.18
- LoFric (Device) $27.95
- TOVIAZ (Drug) $26.37
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Rockford
Mark Cormier, M.d, M.D
Urology — Payments: $85,271
Urology $85,271
Douglas Roegner, M.d, M.D
Urology — Payments: $10,425
Urology $10,425
Michael Fumo, M.d, M.D
Urology — Payments: $7,990
Urology $7,990
Daniel Houlihan, D.o, D.O
Urology — Payments: $4,256
Urology $4,256
Dr. Luke Frederick, Md, MD
Urology — Payments: $4,024
Urology $4,024
Richard Valadez, M.d, M.D
Urology — Payments: $1,555
Urology $1,555